Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2024-09-17 00:00:00 ET · period of report 2024-09-14 · accession 0001415889-24-023550 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-17 | 2024-09-16 | ANAB | Lizzul Paul F. | Chief Medical Off | S - Sale+OE | $38.93 | -2,220 | 15.4K | -13% | -$86.4K |
| D | 2024-09-17 | 2024-09-14 | ANAB | Lizzul Paul F. | Chief Medical Off | M - OptEx | — | +6,000 | 17.6K | +52% | — |
| D | 2024-09-17 | 2024-09-14 | ANAB | Lizzul Paul F. | Chief Medical Off | M - OptEx | $0.00 | -6,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-16 | S | D | 2,220 | $38.93 | 15,398 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-14 | M | A | 6,000 | — | 17,618 | D | — | — | (F1) Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
| 3 | Derivative | Restricted Stock Unit | 2024-09-14 | M | D | 6,000 | $0.00 | 0 | D | — · — to — | 6,000 Common Stock | (F1) Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F3) 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |